A Longitudinal Study of the Effect of Genistein on Bone in Two Different Murine Models of Diminished Estrogen-Producing Capacity
Table 2
Ex vivo microcomputed tomography measures of bone microarchitectural changes in treated mice.
μCT parameters (units)
Treatments (/group)
SHM
OVX
S + V
O + G
SVG
Pooled SEM
-value
L5 Vertebral body: trabecular
BV/TV, (%)
0.6
<0.0001
BV, (mm3)
0.019
<0.005
Tb.N, (mm-1)
0.116
<0.05
Tb.Th, (μm)
1
<0.0001
Tb.Sp, (μm)
305
367
342
367
341
16
NS
Distal femur: trabecular
BV/TV, (%)
2.62
2.05
2.39
1.90
2.00
0.08
NS
BV, (mm3)
0.066
0.057
0.062
0.46
0.53
0.01
NS
Tb.N, (mm-1)
2.21
1.94
2.01
1.91
2.07
0.20
NS
Tb.Th, (μm)
41
42
44
43
40
2
NS
Tb.Sp, (μm)
446
522
500
524
483
22
NS
Midshaft femur: cortical
Area (mm2)
0.014
<0.05
Ct.Th, (m)
0.003
<0.001
BV (mm3)
0.004
<0.05
Data represent the group means. -values are for one-way ANOVA tests. Different letters indicate means that are statistically different based on Tukey-Kramer post hoc test.